Clinical trials: Sepsis Induced Myocardial Dysfunction
Sepsis Induced Myocardial Dysfunction
The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula
The goal of this clinical trial is to learn if Chinese medicine - Yiqilishui formula works to treat sepsis-induced myocardial dysfunction (SIMD). It will also learn about the safety of Yiqilishui formula.
- Trial name
- YQSIMD (NCT06686355)
- Testing
- Yiqilishui formula
- Where
- China
- Volunteers
- 80 people
- Sponsor
- Dongzhimen Hospital, Beijing
Sepsis-Induced Myocardial Dysfunction
Investigating the Clinical Benefits and Underlying Mechanisms of Danhong Injection in Modulating Mitochondrial Homeostasis Against Sepsis-Associated Myocardial Dysfunction
This study aims to evaluate the clinical efficacy of Danhong injection in patients with septic myocardial injury through a prospective randomized controlled trial.
- Trial name
- NCT07375862
- Testing
- Danhong injection, Saline
- Volunteers
- 140 people
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Sepsis Induced Cardiomyopathy, Sepsis Induced Myocardial Dysfunction
Sepsis Induced Myocardial Injury in Critically Ill Children
Sepsis is a dysregulated immune response due to infection, leading to life-threatening organ dysfunction affecting respiratory, renal, immunological, digestive, neurological, and cardiovascular organs.
- Trial name
- NCT07497139
- Testing
- observational study
- Where
- Egypt
- Volunteers
- 84 people
- Sponsor
- Assiut University